SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 147 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 5.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $269,695 | -11.5% | 11,665 | +0.3% | 0.00% | 0.0% |
| Q2 2023 | $304,807 | +38.2% | 11,625 | +35.6% | 0.00% | 0.0% |
| Q1 2023 | $220,618 | -13.4% | 8,571 | -12.5% | 0.00% | 0.0% |
| Q4 2022 | $254,742 | +12.2% | 9,794 | +22.8% | 0.00% | 0.0% |
| Q3 2022 | $227,000 | -62.0% | 7,977 | -24.6% | 0.00% | 0.0% |
| Q1 2022 | $597,000 | -27.7% | 10,582 | -20.5% | 0.00% | -50.0% |
| Q4 2021 | $826,000 | -8.5% | 13,314 | -6.5% | 0.00% | -33.3% |
| Q3 2021 | $903,000 | -33.2% | 14,237 | -13.1% | 0.00% | -25.0% |
| Q2 2021 | $1,351,000 | +39.1% | 16,390 | +24.2% | 0.00% | +33.3% |
| Q1 2021 | $971,000 | +4.2% | 13,198 | +2.7% | 0.00% | 0.0% |
| Q4 2020 | $932,000 | – | 12,851 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |